No la perdemos de vista. Nueva señal de fortaleza en Vertex Pharmaceutical que consigue perforar la resistencia de los 491,80 dólares. La compañía confirma un throw back a la media de 200 ...
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...
El regreso del ‘Buzz Cut’ El corte al ras nunca va a pasar de moda. Al contrario de lo que afirmamos en la introducción, es cómodo y una opción perfecta para los calores de Tucumán. Este ...
Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback